Novo settles off-label suits for $26.7M; Lilly inks Forteo marketing pact with Synthes;

@FiercePharma: France suspends Takeda's Actos on cancer data. Item | Follow @FiercePharma

> Danish drugmaker Novo Nordisk says it will pay $26.7 million to resolve two U.S. Justice Department investigations into improper marketing of its products. Report

> A Chicago jury awarded $625,000 to the estate of a man dosed with Baxter International's blood thinner heparin, which contained a contaminated ingredient found in the company's supply chain in China. News

> Eli Lilly has signed a deal with Swiss company Synthes to co-promote the bone drug Forteo and develop other potential orthopedic treatments. Story

> Deirdre Connelly, the North American president of GlaxoSmithKline, helped break ground and plant trees Thursday as the drugmaker put down a new corporate footprint in Philadelphia's Navy Yard. Item

> A novel variant of swine flu has emerged in Asia with a genetic adaptation giving some resistance to Roche's Tamiflu and GlaxoSmithKline's Relenza, the two mainstay drugs used to tackle the disease. Article

> Contract drugmaker Patheon posted a quarterly loss hurt by contract cancellations and a weaker U.S. dollar. Piece

Biotech News

@FierceBiotech: Pfizer unveils $100M Boston effort to spark R&D innovation. News | Follow @FierceBiotech

@JohnCFierce: Quick shout out to the people who submitted close to 50 Fierce 15 nominations in the first 24 hours. Keep those cards and letters coming! Follow @JohnCFierce

> Micromet drug shows promise against severe blood cancer. Article

> Novartis vax against MenB shows benefits in infant study. News

> Ambit bounces back from dropped IPO with $30M round. Report 

> Obesity field gets boost with $6.2M round for Gelesis. Item

Most Popular This Week

> Alzheimer's biomarker market to reach $9B in decade. Item

> Pfizer embarks on a 'first' all-electronic clinical trial. Story

> Roche, Merck to collaborate on cancer diagnostics. Article

> FDA steps in to prevent drug shortages. Report

> Obesity vaccine would suppress hunger hormone. Story

> Cholera molecule helps cocaine addicts kick the habit. Article

> Adult vaccines cut down on healthcare costs. Piece

> Pfizer plots another $1B in cost cuts. Article

> Pfizer unveils $100M Boston effort to spark R&D innovation. Report

And Finally... A six-week exercise training program can help relieve symptoms of generalized anxiety disorder, according to the first-ever trial to investigate whether physical activity helps patients with the condition. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.